Authors

• Erica Lammerhirt Ottoni
• Rahul Kumar Banerjee (ORCID: https://orcid.org/0000-0003-3781-5441)
• Cesar Rodriguez (ORCID: https://orcid.org/0009-0009-8240-5469)
• Alfred L. Garfall (ORCID: https://orcid.org/0000-0003-2791-5748)
• Robert M. Rifkin (ORCID: https://orcid.org/0000-0003-3141-1518)
• Cyrus Khandanpour (ORCID: https://orcid.org/0000-0003-4655-6269)
• Elena Zamagni (ORCID: https://orcid.org/0000-0003-1422-7305)
• Sara Rockwell
• Yi Lin (ORCID: https://orcid.org/0000-0002-1556-6416)
• Laurent Frenzel (ORCID: https://orcid.org/0000-0002-6085-2163)
• Humberto Villefort

Institutions

• Hôpital Necker-Enfants Malades (FR)
• Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA)
• Mayo Clinic (US)
• AC Camargo Hospital (BR)
• Hospital Moinhos de Vento (BR)
• Fred Hutch Cancer Center (US)
• Universitäres Kinderwunschzentrum Lübeck (DE)
• University Hospital Schleswig-Holstein (DE)
• Istituto di Ematologia di Bologna (IT)
• Florida Cancer Specialists & Research Institute (US)
• Azienda USL di Bologna (IT)
• Mayo Clinic in Arizona (US)
• Technical University of Applied Sciences Lübeck (DE)
• Rocky Mountain Cancer Centers (US)
• Mayo Clinic in Florida (US)
• University of Pennsylvania (US)
• Philadelphia University (US)
• University of Lübeck (DE)
• University of Bologna (IT)
• Icahn School of Medicine at Mount Sinai (US)

Publication Details

Journal

Frontiers in Oncology

Published

2025-07-30

DOI

https://doi.org/10.3389/fonc.2025.1630146

Citations

3

Primary Topic

Monoclonal and Polyclonal Antibodies Research

Type

article

Field-Weighted Citation Impact

4.08